Inflammatory Bowel Syndrome (IBD) Platform Page
Certara’s Inflammatory Bowel Disease (IBD) QSP Platform Model is based on a mechanistic multi-state mathematical model to predict disease activity scores.
Immuno-oncology Simulator™ Page
Certara’s QSP modeling platform for immuno-oncology predicts optimal combinations, dose regimens, and biomarkers in virtual patients, for IO therapies.
Immunogenicity Simulator Page
Certara’s Immunogenicity (IG) Simulator is a QSP immunogenicity prediction tool that predicts immunogenicity incidence and its impact on PK/PD.
Vaccine Simulator Page
Certara’s Vaccine Simulator uses Quantitative Systems Pharmacology (QSP) to determine optimal vaccine dosing strategies for patients.
Simcyp Version 24: Advancing PBPK capabilities and translating new science and technology into regulatory-accepted predictive modeling Blog Post
Summary With the release of Version 24, the Simcyp Simulator introduces cutting-edge enhancements that further elevate its capabilities. The latest features in Version 24 include: Enhanced user experience with modernized...
Population Pharmacokinetic and Pharmacodynamic Analysis of Navtemadlin in Patients with Relapsed and Refractory (R/R) Myelofibrosis (MF) and Other Myeloid or Solid Tumor Malignancies Blog Post
Abstract This study conducted a population pharmacokinetic (PK) and pharmacodynamic (PD) analysis of navtemadlin, an MDM2 inhibitor, across multiple cancer types, including relapsed and refractory (R/R) myelofibrosis (MF), Merkel cell...
